Skip to main content

Table 3 Adjudicated hospitalization events in the PACE study

From: Rationale and design for the Predictors of Arrhythmic and Cardiovascular Risk in End Stage Renal Disease (PACE) study

Event

Adjudicated based on following clinical criteria

Cardiovascular disease (CVD)

 

Myocardial infarction

Clinical symptoms

Jaw pain or chest Pain

ECG markers

Major Q wave

ST elevation with or without Q wave

Cardiac biomarkers

Troponin I

CK-MB or CK total

Congestive heart failure/Volume overload

Clinical symptoms

Dyspnea on exertion or rest

Pulmonary edema or pulmonary congestion

Radiographic evidence

Inspiratory crackles

S3 gallop

Physical exam

Jugular venous distension

Peripheral edema

Procedures

Atherosclerotic CVD (ASCVD)

Percutaneous transluminal coronary angioplasty (PTCA)

Coronary artery bypass graft (CABG)

Carotid endarterectomy

Abdominal aortic aneurysm repair

Peripheral vascular disease (PVD)

Peripheral angioplasty

Peripheral bypass

Limb amputation

Cerebrovascular Accident (CVA) clinical and supportive CT and MRI evidence

Large artery stenosis

>50% stenosis of major artery

Cerebral cortical impairment

Brainstem/cerebellar dysfunction

Cardioembolism

 

Small-artery occlusion (lacunar)

Clinical lacunar syndromes

No evidence of cortical dysfunction

Other etiology

Nonatherosclerotic vasculopathies

Hypercoagulable states or hematologic disorders

Undetermined etiology

Systemic infections

Sepsis

Central Nervous system

Access -related

Respiratory/GI tract

Fungal

Skin

Peritonitis

Septic Arthritis

Osteomyelitis

Fractures

All

Traumatic

Hip/ Vertebral compression

Traumatic